SCHEMBL14718233

SCHEMBL14718233

Cc1ccc(C(=O)O)c(C)c1N=C=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.37
TRPA1 O75762 2/20 0.37
HAAO P46952 1/20 0.37
CYP1A2 P05177 2/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB2 P47870 2/20 0.35
NOTUM Q6P988 1/20 0.34
MCL1 Q07820 1/20 0.34
TSHR P16473 1/20 0.34
PTGER4 P35408 1/20 0.33
CLCN2 P51788 1/20 0.33
GLO1 Q04760 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1482064 0.86 CYP3A4 (0.37) CYP3A4TRPA1HAAOCYP1A2ALDH1A1
SCHEMBL4431002 0.81 CYP3A4 (0.34) CYP3A4TRPA1ALDH1A1GABRA1GABRB2
SCHEMBL27625555 0.81 CYP3A4 (0.36) CYP3A4TRPA1HAAOCYP1A2ALDH1A1
SCHEMBL3771988 0.79 KDM4E (0.52) CYP3A4TRPA1CYP1A2ALDH1A1KDM4E
SCHEMBL16707396 0.78 CYP3A4 (0.46) CYP3A4TRPA1ALDH1A1HPGDGABRA1
SCHEMBL27999513 0.78 CYP3A4 (0.39) CYP3A4TRPA1ALDH1A1GABRA1GABRB2
SCHEMBL295649 0.76 CYP3A4 (0.50) CYP3A4TRPA1ALDH1A1HPGDGABRA1
SCHEMBL27373461 0.74 CYP3A4 (0.44) CYP3A4TRPA1HAAOCYP1A2ALDH1A1
SCHEMBL10661215 0.74 CYP3A4 (0.40) CYP3A4TRPA1ALDH1A1KDM4EHPGD
SCHEMBL9015287 0.74 CYP3A4 (0.36) CYP3A4TRPA1GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053407-A1 PYRROLO [3,2-D] PYRIMIDIN-3-YL DERIVATIVES USED AS ACTIVATORS OF AMPK GLAXOSMITHKLINE LLC (US) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053407-A1 PYRROLO [3,2-D] PYRIMIDIN-3-YL DERIVATIVES USED AS ACTIVATORS OF AMPK PRKAG2, PRKAB2, PRKAG3 CYP3A4 2255/4885TRPA1 3733/4885HAAO 3857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.